SCHEMBL4956835

SCHEMBL4956835

O=P(O)(O)c1ccccc1-c1ccccc1P(=O)(O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.48
CA4 P22748 1/20 0.48
CA5A P35218 1/20 0.48
PTK2B Q14289 5/20 0.47
POLB P06746 3/20 0.47
NPC1 O15118 2/20 0.47
ALDH1A1 P00352 1/20 0.45
RAB9A P51151 1/20 0.45
ALPG P10696 1/20 0.44
KDM4E B2RXH2 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MAPT P10636 1/20 0.38
SRC P12931 2/20 0.37
CFTR P13569 1/20 0.37
FDPS P14324 1/20 0.37
MEN1 O00255 1/20 0.36
CDC25B P30305 1/20 0.36
KMT2A Q03164 1/20 0.36
APAF1 O14727 1/20 0.36
TDP2 O95551 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7263443 0.89 ALDH1A1 (0.43) CA2CA4CA5APTK2BPOLB
SCHEMBL6889688 0.87 POLB (0.44) CA2CA4CA5APTK2BPOLB
SCHEMBL563975 0.85 POLB (0.47) CA2CA4CA5APTK2BPOLB
SCHEMBL2173729 0.85 CA2 (0.55) CA2CA4CA5APTK2BPOLB
SCHEMBL29733396 0.85 CA2 (0.55) CA2CA4CA5APTK2BPOLB
SCHEMBL27902996 0.83 ACP3 (0.46) CA2PTK2BPOLBKDM4EMEN1
SCHEMBL30729584 0.82 ACP3 (0.47) CA2CA4CA5APTK2BPOLB
SCHEMBL11440966 0.82 PTK2B (0.40) CA2CA4CA5APTK2BPOLB
SCHEMBL22499728 0.80 ABL1 (0.48) PTK2BPOLBNPC1ALDH1A1RAB9A
SCHEMBL232481 0.79 CA2 (0.44) CA2CA4CA5APTK2BPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397399-A2 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES G2O Water Technologies Limited (GB) 2024-07-10 EP claimed
CN-117624629-A Hydrogen bond organic framework material with ultrahigh proton conductivity and preparation method and application thereof 陕西科技大学 2024-03-01 CN claimed
EP-3774001-A1 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES G2O Water Technologies Limited (GB) 2021-02-17 EP claimed
US-20210016232-A1 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES EVOVE LTD (GB) 2021-01-21 US claimed
WO-2018204595-A1 METAL ORGANIC FRAMEWORKS, THEIR SYNTHESIS AND USE ExxonMobil Research an Engineering Company (US) 2018-11-08 WO claimed
US-20180318815-A1 METAL ORGANIC FRAMEWORKS, THEIR SYNTHESIS AND USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2018-11-08 US claimed
US-12629639-B2 Spacer for a spiral wound membrane EVOVE LTD (GB) 2026-05-19 US disclosed
EP-4397399-A2 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES G2O Water Technologies Limited (GB) 2024-07-10 EP disclosed
US-20240157304-A1 SPACER FOR A SPIRAL WOUND MEMBRANE EVOVE LTD (GB) 2024-05-16 US disclosed
US-20240149223-A1 MEMBRANE DEVICE EVOVE LTD (GB) 2024-05-09 US disclosed
CN-117624629-A Hydrogen bond organic framework material with ultrahigh proton conductivity and preparation method and application thereof 陕西科技大学 2024-03-01 CN disclosed
CN-117624629-A Hydrogen bond organic framework material with ultrahigh proton conductivity and preparation method and application thereof 陕西科技大学 2024-03-01 CN disclosed
EP-4304766-A1 MEMBRANE DEVICE Evove Ltd (GB) 2024-01-17 EP disclosed
WO-2022189785-A1 SPACER FOR A SPIRAL WOUND MEMBRANE EVOVE LTD (GB) 2022-09-15 WO disclosed
WO-2022189793-A1 MEMBRANE DEVICE EVOVE LTD (GB) 2022-09-15 WO disclosed
EP-3774001-A1 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES G2O Water Technologies Limited (GB) 2021-02-17 EP disclosed
US-20210016232-A1 MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES EVOVE LTD (GB) 2021-01-21 US disclosed
WO-2018204595-A1 METAL ORGANIC FRAMEWORKS, THEIR SYNTHESIS AND USE ExxonMobil Research an Engineering Company (US) 2018-11-08 WO disclosed
US-20180318815-A1 METAL ORGANIC FRAMEWORKS, THEIR SYNTHESIS AND USE EXXONMOBIL RESEARCH AND ENGINEERING COMPANY 2018-11-08 US disclosed
WO-2008039959-A2 COMPOSITE STRUCTURE WITH ORGANOPHOSPHONATE ADHERENT LAYER AND METHOD OF PREPARING ACULON INC. (US) 2008-04-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12629639-B2 Spacer for a spiral wound membrane AQP1, AQP3, AQP4 CA2 3918/4885CA4 4432/4885CA5A 4148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.